Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yongye International is an agricultural biotechnology company based in China that specializes in the development, manufacturing, and sale of fulvic acid-based plant and animal nutrients. The company's flagship product, Shengmingsu, is a liquid nutrient for plants that enhances crop yields and quality by improving nutrient absorption. Yongye also produces Bose, a nutrient for livestock designed to improve growth rates and health. While primarily focused on the agricultural sector, the company utilizes biotechnology processes to extract and refine organic compounds for large-scale commercial use. Formerly listed on the NASDAQ, the company transitioned to a private entity following a management-led buyout.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yongye Biotechnology International.